Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.
<h4>Background</h4>To evaluate if plasma levels of midregional pro-adrenomedullin (MR-proADM) improve prediction of functional outcome in ischemic stroke.<h4>Methods</h4>In 168 consecutive ischemic stroke patients, plasma levels of MR-proADM were measured within 24 hours from...
Guardado en:
Autores principales: | Thomas Seifert-Held, Thomas Pekar, Thomas Gattringer, Nicole E Simmet, Hubert Scharnagl, Christoph Bocksrucker, Christian Lampl, Maria K Storch, Tatjana Stojakovic, Franz Fazekas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b43829b2e50141c1bac2f462fdc5e100 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells
por: Ashley J. Clark, et al.
Publicado: (2021) -
The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke
por: Pawluk H, et al.
Publicado: (2020) -
Maternal neurofascin-specific autoantibodies bind to structures of the fetal nervous system during pregnancy, but have no long term effect on development in the rat.
por: Sonja Hochmeister, et al.
Publicado: (2014) -
Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study
por: Teruhide Koyama, et al.
Publicado: (2021) -
Author Correction: Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study
por: Teruhide Koyama, et al.
Publicado: (2021)